| Dementia and Cognitive Impairment Research | Lifetime | 81 | NL 4 | 99.69 |
| Alzheimer's disease research and treatments | Lifetime | 103 | NL 3 | 99.72 |
| S100 Proteins and Annexins | Lifetime | 45 | NL 2 | 99.19 |
| Multiple Sclerosis Research Studies | Lifetime | 145 | NL 3 | 99.02 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 397 | NL 10 | 98.62 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 129 | NL 7 | 98.25 |
| Skin and Cellular Biology Research | Lifetime | 236 | NL 8 | 96.82 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 437 | NL 21 | 96.54 |
| Folate and B Vitamins Research | Lifetime | 775 | NL 31 | 95.22 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 533 | NL 26 | 96.20 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 460 | NL 13 | 95.24 |
| Polyomavirus and related diseases | Lifetime | 920 | NL 14 | 93.85 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 969 | NL 25 | 92.26 |
| Peripheral Neuropathies and Disorders | Lifetime | 878 | NL 42 | 94.25 |
| GDF15 and Related Biomarkers | Lifetime | 571 | NL 13 | 80.55 |
| Clusterin in disease pathology | Lifetime | 374 | NL 8 | 68.01 |
| Alzheimer's disease research and treatments | 2021-2025 | 9 | NL 1 | 99.92 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 9 | NL 1 | 99.92 |
| S100 Proteins and Annexins | 2021-2025 | 2 | NL 1 | 98.87 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 33 | NL 1 | 98.98 |
| Amyotrophic Lateral Sclerosis Research | 2021-2025 | 84 | NL 6 | 96.39 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 791 | NL 52 | 94.00 |
| Multiple Sclerosis Research Studies | 2021-2025 | 247 | NL 6 | 95.99 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 180 | NL 8 | 94.81 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 505 | NL 10 | 94.43 |
| Skin and Cellular Biology Research | 2021-2025 | 55 | NL 2 | 91.79 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 196 | NL 4 | 92.71 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 267 | NL 10 | 86.83 |
| Prion Diseases and Protein Misfolding | 2021-2025 | 139 | NL 2 | 84.83 |
| Neurogenesis and neuroplasticity mechanisms | 2021-2025 | 358 | NL 4 | 82.55 |
| Polyomavirus and related diseases | 2021-2025 | 512 | NL 7 | 80.14 |
| Bioinformatics and Genomic Networks | 2021-2025 | 911 | NL 16 | 78.60 |
| Hereditary Neurological Disorders | 2021-2025 | 378 | NL 20 | 73.57 |
| Cholinesterase and Neurodegenerative Diseases | 2021-2025 | 956 | NL 5 | 71.61 |
| Cell Adhesion Molecules Research | 2021-2025 | 991 | NL 46 | 67.76 |
| Inflammation biomarkers and pathways | 2021-2025 | 351 | NL 7 | 46.88 |
| Ginkgo biloba and Cashew Applications | 2021-2025 | 970 | NL 2 | 26.34 |
